Bora Pharmaceuticals Co., LTD. 6472.TWO Stock
Bora Pharmaceuticals Co., LTD. Price Chart
Bora Pharmaceuticals Co., LTD. 6472.TWO Financial and Trading Overview
Bora Pharmaceuticals Co., LTD. stock price | 678 TWD |
Previous Close | 728 TWD |
Open | 730 TWD |
Bid | 712 TWD x 0 |
Ask | 715 TWD x 0 |
Day's Range | 712 - 733 TWD |
52 Week Range | 191.74 - 850 TWD |
Volume | 1.44M TWD |
Avg. Volume | 3.46M TWD |
Market Cap | 54.92B TWD |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | 23.973063 |
EPS (TTM) | 0 TWD |
Forward Dividend & Yield | 8 (1.11%) |
Ex-Dividend Date | July 6, 2023 |
1y Target Est | 936 TWD |
6472.TWO Valuation Measures
Enterprise Value | 57.89B TWD |
Trailing P/E | 23.973063 |
Forward P/E | 16.11954 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 3.8792455 |
Price/Book (mrq) | 9.939275 |
Enterprise Value/Revenue | 4.089 |
Enterprise Value/EBITDA | 16.33 |
Trading Information
Bora Pharmaceuticals Co., LTD. Stock Price History
Beta (5Y Monthly) | N/A |
52-Week Change | 235.19% |
S&P500 52-Week Change | 20.43% |
52 Week High | 850 TWD |
52 Week Low | 191.74 TWD |
50-Day Moving Average | 769.38 TWD |
200-Day Moving Average | 496.76 TWD |
6472.TWO Share Statistics
Avg. Volume (3 month) | 3.46M TWD |
Avg. Daily Volume (10-Days) | 2.02M TWD |
Shares Outstanding | 77.14M |
Float | N/A |
Short Ratio | N/A |
% Held by Insiders | 46.50% |
% Held by Institutions | 12.43% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 8 |
Trailing Annual Dividend Yield | 1.09% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0.1091 |
Last Split Factor | 1100.4294:1000 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 15.90% |
Operating Margin (ttm) | 22.72% |
Gross Margin | 31.42% |
EBITDA Margin | 25.03% |
Management Effectiveness
Return on Assets (ttm) | 13.24% |
Return on Equity (ttm) | 49.23% |
Income Statement
Revenue (ttm) | 14.16B TWD |
Revenue Per Share (ttm) | 187.78 TWD |
Quarterly Revenue Growth (yoy) | 327.89% |
Gross Profit (ttm) | 2.91B TWD |
EBITDA | 3.54B TWD |
Net Income Avi to Common (ttm) | 2.25B TWD |
Diluted EPS (ttm) | 29.7 |
Quarterly Earnings Growth (yoy) | 480.10% |
Balance Sheet
Total Cash (mrq) | 4.98B TWD |
Total Cash Per Share (mrq) | 65.22 TWD |
Total Debt (mrq) | 6.7B TWD |
Total Debt/Equity (mrq) | 110.08 TWD |
Current Ratio (mrq) | 1.171 |
Book Value Per Share (mrq) | 71.635 |
Cash Flow Statement
Operating Cash Flow (ttm) | 3.91B TWD |
Levered Free Cash Flow (ttm) | 3.18B TWD |
Profile of Bora Pharmaceuticals Co., LTD.
Country | Taiwan |
State | N/A |
City | Taipei |
Address | 26, Ruiguang Road |
ZIP | 114 |
Phone | 886 2 2790 1555 |
Website | https://www.bora-corp.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Bora Pharmaceuticals Co., LTD. engages in the research, development, production, marketing, sale, and distribution of pharmaceutical products worldwide. It manufactures and sells generic, brand, and over-the-counter (OTC) drugs. The company is involved in contract development and manufacturing; consumer healthcare and OTC; and prescription drugs businesses. It also provides clinical and commercial manufacturing services, including solvent manufacturing; solid and liquid dosage forms; extrusion spheronization; immediate and extended release; core, sugar-coated, and film-coated tablets; fixed-dose combination products; and granules, and liquids sachet/stick pack filling. In addition, the company offers pharmaceutical development services, such as liquid and solid dosage forms, and immediate and modified release, analytical method development and validation; packaging and serialization services, which include bottle and blister packaging, and sachets; and raw materials and finished products testing, and analytical techniques services, as well as method verification, validation, and transfer. Further, it provides OTC medicines, foods and vitamins supplements; and skincare products. Additionally, the company offers market analysis, drug and regulatory related services, price development, GDP warehousing, distribution, packaging, marketing planning, and sales services. The company's sales and distribution network comprising of medical centers, hospitals, clinics, pharmacies, drug stores, CVS, and specialty channels. Bora Pharmaceuticals Co., LTD. was incorporated in 2007 and is based in Taipei, Taiwan.
Q&A For Bora Pharmaceuticals Co., LTD. Stock
What is a current 6472.TWO stock price?
Bora Pharmaceuticals Co., LTD. 6472.TWO stock price today per share is 678 TWD.
How to purchase Bora Pharmaceuticals Co., LTD. stock?
You can buy 6472.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Bora Pharmaceuticals Co., LTD.?
The stock symbol or ticker of Bora Pharmaceuticals Co., LTD. is 6472.TWO.
Which industry does the Bora Pharmaceuticals Co., LTD. company belong to?
The Bora Pharmaceuticals Co., LTD. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Bora Pharmaceuticals Co., LTD. have in circulation?
The max supply of Bora Pharmaceuticals Co., LTD. shares is 101.49M.
What is Bora Pharmaceuticals Co., LTD. Price to Earnings Ratio (PE Ratio)?
Bora Pharmaceuticals Co., LTD. PE Ratio is 0.00000000 now.
What was Bora Pharmaceuticals Co., LTD. earnings per share over the trailing 12 months (TTM)?
Bora Pharmaceuticals Co., LTD. EPS is 0 TWD over the trailing 12 months.
Which sector does the Bora Pharmaceuticals Co., LTD. company belong to?
The Bora Pharmaceuticals Co., LTD. sector is Healthcare.